principles extracted from urine (Afiller and Turner, 1943) and from serum (Foster and Miller, 1950) cause leukaemoid effects of myeloid and of lymphatic type respectively when injected into normal animals. Furthermore, myelokentric acid has induced partial remissions in human cases of lymphoblastic leukaemia in the hands of Miller, Herbutt and Jones (1947) . Hence hormonal imbalance may play a part in the aetiology of leukaemia. Finkelstein, Gordon and Charipper (1944) demonstrated that oestrogens have a depressant effect on the bone-marrow in certain conditions, but they did not study leukaemic states. Burrows and Horning (1952) have shown that not only are oestrogens careinoaenic, but they may be careinostatic, often restraining and causing regression of some human neoplasms such as carcinomata of the breast and prostate. They also state that the liabihty of mice to leucosis can be increased by oestrogens and reduced by androgens. Furth (1952) , however, reminds us that in most strains of mice loukaemia is more common in the female, but in man it is more common in males. It is possible, therefore, that in human leukaemia oestrogens may have the opposite effect to that in niiee. Dausset and Schwarzman (1951) reported a study of 212 cases of acute leukaemia witb, regard to the influence of age and sex upon the frequency and cytological types. They also reviewed other series in the literature from these points of view, including both acute and chronic leukaemia. These authors state that between 18 and 50 years in both males and females there is an overwhelrning preponderance of myeloid leukaemia, while under the age of 18 and over the age of 50 lymphoid leukaemia occurs almost exclusively. As the former occurs most commonly during the period of maximal procreative activity, they suggest that there may be an endocrine effect on the lymphatic-mye-loid equilibrium, especially with regard to the sex hormones.
Stilb'oestrol appears to have had a beneficial effect in single cases of chronic myeloid leukaemia (Loeper, LeSourd and Sterboul, 1947) and of chronic lymphatic leukaemia (Lemaire, Loeper, Housset and Koupernik, 1947 Bearing in mind that remissions iin acute leukaemia may rarely be spontaneous, or that they may be induced by blood transfusions and/or antibiotics, in 2 of' these 3 cases there was some suggestive evidence of transient benefit from stilboestrol itself. Case 2 had had penicillin therapy and three blood transfusions, each of two bottles of blood, over a period of 20 days elsewhere without improvement. His clinical condition had deteriorated, while the haemoglobin level had fallen from 48 per cent to 42 per cent, and the red cell count from 2-6 m. to 1-9 m. per c.mm. during this time. On admission to hospital in Sheffield he was given 3 pints of packed cells and stilboestrol and penicillin therapy were begun. This was followed by an excellent clinical remission for 6 weeks, with complete disappearance of clinical splenomegaly and hepatomegaly, the latter organs having been palpable 2 in. below the respective costal margins at the commencement of treatment. Two days after the blood transfusion the haemoglobin level was 8.9 g. per 100 ml. and the total leucocyte count 800 per c.mm. Over the next few weeks his haemoglobin level rose to 12.6 g./100 ml., while the total leucocyte count reached 6000 per c.mm., the only abnormal cell in the peripheral blood being an occasional (1 per cent) blast form. When Case 6 was admitted to hospital, she had gross gum hypertrophy, and a spleen palpable 11 in. below the left costal margin. Her haemoglobin level was 7.8 g./100 ml. Ten days after the commencement of stilboestrol therapy only, she was subjectively much improved, the gum hypertrophy had diminished considerably, and the spleen was impalpable, while the haemoglobin level had risen to 8.1 g./100 ml. Three days later additional blood transfusion therapy was begun.
Stilboestrol was well tolerated in most cases, and toxic effects were few. Nausea and vomiting led to the abandonment of this therapy in Case 13 after 5 days, while Cases 6 and 15 experienced transient nausea only in the first few days of treatment. Slight mammary hypertrophy and increased areolar pigmentation were noted in Cases 2, 3, 6 and 14.
SUMMARY AND CONCLUSIONS.
Fifteen cases of acute leukaemia (8 myeloblastic and 7 monoblastic) were treated with stilboestrol. None lived for more than 5 months after beginning therapy. No complete remissions occurred, but 3 patients had transient partial remissions.
There is no evidence from this series to suggest that either the prognosis or the clinical course of acute leukaemia is altered by adding stilboestrol to other therapy.
I am indebted to my medical and surgical colleagues in Sheffield, to Dr. R. T. Gaunt, of Chesterfield, and to Dr. Peter Milligan, of Doncaster, for referring their cases. Thanks are also due to Professor E. J. Wayne and Dr. G. M. Wilson for reading and criticising the manuscript.
